Cellular and synaptic adaptations mediating opioid dependence - PubMed
Review
Cellular and synaptic adaptations mediating opioid dependence
J T Williams et al. Physiol Rev. 2001 Jan.
Free article
Abstract
Although opioids are highly effective for the treatment of pain, they are also known to be intensely addictive. There has been a massive research investment in the development of opioid analgesics, resulting in a plethora of compounds with varying affinity and efficacy at all the known opioid receptor subtypes. Although compounds of extremely high potency have been produced, the problem of tolerance to and dependence on these agonists persists. This review centers on the adaptive changes in cellular and synaptic function induced by chronic morphine treatment. The initial steps of opioid action are mediated through the activation of G protein-linked receptors. As is true for all G protein-linked receptors, opioid receptors activate and regulate multiple second messenger pathways associated with effector coupling, receptor trafficking, and nuclear signaling. These events are critical for understanding the early events leading to nonassociative tolerance and dependence. Equally important are associative and network changes that affect neurons that do not have opioid receptors but that are indirectly altered by opioid-sensitive cells. Finally, opioids and other drugs of abuse have some common cellular and anatomical pathways. The characterization of common pathways affected by different drugs, particularly after repeated treatment, is important in the understanding of drug abuse.
Similar articles
-
Bie B, Pan ZZ. Bie B, et al. Mol Pain. 2005 Feb 9;1:7. doi: 10.1186/1744-8069-1-7. Mol Pain. 2005. PMID: 15813995 Free PMC article.
-
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.
Christie MJ. Christie MJ. Br J Pharmacol. 2008 May;154(2):384-96. doi: 10.1038/bjp.2008.100. Epub 2008 Apr 14. Br J Pharmacol. 2008. PMID: 18414400 Free PMC article. Review.
-
Herráez-Baranda LA, Carretero J, González-Sarmiento R, Laorden ML, Milanés MV, Rodríguez RE. Herráez-Baranda LA, et al. Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):166-73. doi: 10.1016/j.molbrainres.2005.03.003. Epub 2005 Apr 22. Brain Res Mol Brain Res. 2005. PMID: 15950775
-
Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence.
Liu JG, Anand KJ. Liu JG, et al. Brain Res Brain Res Rev. 2001 Dec;38(1-2):1-19. doi: 10.1016/s0165-0173(01)00057-1. Brain Res Brain Res Rev. 2001. PMID: 11750924 Review.
Cited by
-
Sanders NC, Mancino MJ, Gentry WB, Guise JB, Bickel WK, Thostenson J, Oliveto AH. Sanders NC, et al. Exp Clin Psychopharmacol. 2013 Aug;21(4):294-302. doi: 10.1037/a0033724. Epub 2013 Jul 15. Exp Clin Psychopharmacol. 2013. PMID: 23855333 Free PMC article. Clinical Trial.
-
Tapocik JD, Luu TV, Mayo CL, Wang BD, Doyle E, Lee AD, Lee NH, Elmer GI. Tapocik JD, et al. Addict Biol. 2013 May;18(3):480-95. doi: 10.1111/j.1369-1600.2012.00470.x. Epub 2012 Jul 15. Addict Biol. 2013. PMID: 22804800 Free PMC article.
-
Almela P, Cerezo M, Milanés MV, Laorden ML. Almela P, et al. Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):374-82. doi: 10.1007/s00210-006-0032-y. Epub 2006 Feb 11. Naunyn Schmiedebergs Arch Pharmacol. 2006. PMID: 16474935
-
Opioid-receptor-heteromer-specific trafficking and pharmacology.
van Rijn RM, Whistler JL, Waldhoer M. van Rijn RM, et al. Curr Opin Pharmacol. 2010 Feb;10(1):73-9. doi: 10.1016/j.coph.2009.09.007. Epub 2009 Oct 19. Curr Opin Pharmacol. 2010. PMID: 19846340 Free PMC article. Review.
-
Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia.
Takayama N, Ueda H. Takayama N, et al. J Neurosci. 2005 Jan 12;25(2):430-5. doi: 10.1523/JNEUROSCI.3170-04.2005. J Neurosci. 2005. PMID: 15647486 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials